HXN5003

· Helixon Biotechnology (Suzhou) Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HXN5003, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants [Phase 1]